Enterome Completes €46.3 Million ($52.6 Million) Financing to Progress the Clinical Development of Its Therapeutic Pipeline

Lead 'OncoMimics' candidate EO2401 planned to start first clinical trials for Glioblastoma and Adrenal Tumors during mid-2020

PARIS and CAMBRIDGE, Massachusetts, June 25, 2020 -- (Healthcare Sales & Marketing Network) -- ENTEROME SA, a clinical-stage b... Biopharmaceuticals, Oncology, Venture Capital Enterome, microbiome-immunoinflammation, immunotherapy

Source: HSMN NewsFeed - June 25, 2020 Category: Pharmaceuticals Source Type: news